These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 11189415)

  • 1. [Functional domains study of topoisomerase I].
    Cao P
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(4):416-8. PubMed ID: 11189415
    [No Abstract]   [Full Text] [Related]  

  • 2. A type IB topoisomerase with DNA repair activities.
    Belova GI; Prasad R; Kozyavkin SA; Lake JA; Wilson SH; Slesarev AI
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6015-20. PubMed ID: 11353838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human topoisomerase I promotes HIV-1 proviral DNA synthesis: implications for the species specificity and cellular tropism of HIV-1 infection.
    Shoya Y; Tokunaga K; Sawa H; Maeda M; Ueno T; Yoshikawa T; Hasegawa H; Sata T; Kurata T; Hall WW; Cullen BR; Takahashi H
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8442-7. PubMed ID: 12829794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human topoisomerase I damage response plays a role in apoptosis.
    Søe K; Rockstroh A; Schache P; Grosse F
    DNA Repair (Amst); 2004 Apr; 3(4):387-93. PubMed ID: 15010314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of full length topoisomerase I from Thermotoga maritima.
    Hansen G; Harrenga A; Wieland B; Schomburg D; Reinemer P
    J Mol Biol; 2006 May; 358(5):1328-40. PubMed ID: 16600296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thirteen-exon-motif signature for vertebrate nuclear and mitochondrial type IB topoisomerases.
    Zhang H; Meng LH; Zimonjic DB; Popescu NC; Pommier Y
    Nucleic Acids Res; 2004; 32(7):2087-92. PubMed ID: 15096574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symposium: downstream from topoisomerase-DNA lesions: life-or-death consequences for the cell.
    Kohn KW; Andoh T
    Cell Biochem Biophys; 2000; 33(2):171-3. PubMed ID: 11325036
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a minimal functional linker in human topoisomerase I by domain swapping with Cre recombinase.
    Frøhlich RF; Juul S; Nielsen MB; Vinther M; Veigaard C; Hede MS; Andersen FF
    Biochemistry; 2008 Jul; 47(27):7127-36. PubMed ID: 18553933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I.
    Ayrault O; Karayan L; Riou JF; Larsen CJ; Séité P
    Oncogene; 2003 Apr; 22(13):1945-54. PubMed ID: 12673200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Topoisomerase I in alternative splicing].
    Jeanteur P
    Bull Cancer; 2003 Dec; 90(12):1033-4. PubMed ID: 14715421
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of poly(ADP-ribose) in the DNA damage signaling network.
    Malanga M; Althaus FR
    Biochem Cell Biol; 2005 Jun; 83(3):354-64. PubMed ID: 15959561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SF2/ASF protein binds to the cap region of human topoisomerase I through two RRM domains.
    Kowalska-Loth B; Girstun A; Trzcińska AM; Piekiełko-Witkowska A; Staroń K
    Biochem Biophys Res Commun; 2005 Jun; 331(2):398-403. PubMed ID: 15850773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of a novel ATP-independent type I DNA topoisomerase from a marine methylotroph.
    Kwack MS; Park JE; Park JK; Lee JS
    Arch Biochem Biophys; 2005 May; 437(2):168-77. PubMed ID: 15850556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor suppressor protein p53 stimulates the formation of the human topoisomerase I double cleavage complex in vitro.
    Søe K; Hartmann H; Schlott B; Stevnsner T; Grosse F
    Oncogene; 2002 Sep; 21(43):6614-23. PubMed ID: 12242659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trapping of human DNA topoisomerase I by DNA structures mimicking intermediates of DNA repair.
    Lebedeva N; Rechkunova N; Boiteux S; Lavrik O
    IUBMB Life; 2008 Feb; 60(2):130-4. PubMed ID: 18380002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse gyrase and genome stability in hyperthermophilic organisms.
    Perugino G; Valenti A; D'amaro A; Rossi M; Ciaramella M
    Biochem Soc Trans; 2009 Feb; 37(Pt 1):69-73. PubMed ID: 19143604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RRM proteins interacting with the cap region of topoisomerase I.
    Trzcińska-Daneluti AM; Górecki A; Czubaty A; Kowalska-Loth B; Girstun A; Murawska M; Lesyng B; Staroń K
    J Mol Biol; 2007 Jun; 369(4):1098-112. PubMed ID: 17481653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site.
    Urasaki Y; Laco G; Takebayashi Y; Bailly C; Kohlhagen G; Pommier Y
    Cancer Res; 2001 Jan; 61(2):504-8. PubMed ID: 11212241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A distinct subnuclear localization of mammalian DNA topoisomerase IIbeta in yeast.
    Sakaguchi A; Akashi T; Kikuchi A
    Biochem Biophys Res Commun; 2001 May; 283(4):876-82. PubMed ID: 11350066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA topoisomerases as targets of therapeutics: an overview.
    Wang JC
    Adv Pharmacol; 1994; 29A():1-19. PubMed ID: 7826853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.